Johnson & Johnson’s new prostate cancer advances could signal trouble for Pfizer By: MarketWatch June 06, 2017 at 12:25 PM EDT Two big clinical trials, which have dazzled scientists and Wall Street, are likely to give the company a big leg up. Read More >> Related Stocks: Johnson & Johnson Pfizer